Canocapavir
Canocapavir (ZM-H1505R) has orally antiviral activity. Canocapavir is a HBV capsid inhibitor that can be used in the research of Chronic hepatitis B. [1].
Product Specifications
CAS Number
[2137847-19-7]
Product Name Alternative
ZM-H1505R
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/canocapavir.html
Purity
98.91
Solubility
DMSO : 300 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1NC2=CC=C(C=C2N1)CCN3[C@@](OCC3=O)([H])C4=CN(C5=CC=C(C=C5)Br)N=C4C6=CC=C(C=C6)F
Molecular Formula
C27H21BrFN5O3
Molecular Weight
562.39
References & Citations
[1]WHO Drug Information, Vol. 36, No. 2, 2022.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1164656-01 0.02 mg (E-Coli)
Recombinant Corynebacterium sp. 2,5-diketo-D-gluconic acid reductase A (dkgA)
Ask
View Details MBS1164656-02 0.02 mg (Yeast)
Recombinant Corynebacterium sp. 2,5-diketo-D-gluconic acid reductase A (dkgA)
Ask
View Details MBS1164656-03 0.1 mg (E-Coli)
Recombinant Corynebacterium sp. 2,5-diketo-D-gluconic acid reductase A (dkgA)
Ask
View Details MBS1164656-04 0.1 mg (Yeast)
Recombinant Corynebacterium sp. 2,5-diketo-D-gluconic acid reductase A (dkgA)
Ask
View Details